MUE 09: Parkinson's Disease in Acute Care
** This bulletin supersedes MUE 01 **
Archived February 2022.
Posted: Wednesday, September 5, 2018
Category - Medicines Update Extra
** This bulletin supersedes MUE 01 **
Archived February 2022.
Posted: Monday, August 20, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Friday, July 13, 2018
Category - Medicines Update Extra
** This bulletin supersedes MUE 02 **
Archived April 2024.
April 2024 update:
This bulletin has been replaced with a Medicines Update blog series on QTc prolongation. Blogs in the series include:
Posted: Wednesday, June 20, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Wednesday, May 2, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Wednesday, March 28, 2018
Category - Medicines Update Extra
** This bulletin supersedes MUE 05 **
The FAQ includes:
April 2023 update:
This bulletin is in the process of being replaced with a Medicines Update blog series on DOACs. Blogs in the series published to date include:
Posted: Monday, March 5, 2018
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Monday, December 18, 2017
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Monday, October 30, 2017
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.
Posted: Monday, September 4, 2017
Category - Formulary Update
This post summarises the latest NHS Greater Glasgow and Clyde decisions relating to new medicines considered by the Area Drug and Therapeutics Committee (ADTC) and uses a nationally developed format specifically aimed for patients and the public.
For full details of the medicines included in this post that are available for use, including any restrictions on prescribing, please see the relevant entry in the GGC Formulary.